Karl-Werner Schweppe

No ORCID on file · 91 papers in corpus · active 1981-2026

Study types

  • article 73
  • book-chapter 7
  • other 6
  • review 5

Condition tags

  • endometriosis 56
  • die_deep_infiltrating 21
  • infertility 5
  • adenomyosis 4
  • dyspareunia 3
  • dysmenorrhea 3
  • endometrioma 2
  • bowel_endometriosis 1
  • chronic_pelvic_pain 1
  • bladder_endometriosis 1
article 1989
LH-RH agonist (Buserelin): treatment of endometriosis
Archives of gynecology and obstetrics ·doi:10.1007/bf00934075
article 1989
[Pathophysiology of endometriosis].
Der Gynakologe
article 1988
Auswirkungen der Danazol-Therapie bei Endometriose auf Blutbild und Gerinnung
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2008-1026554

Over a six-month period, 62 endometriosis patients were given 600 mg per day of the ethisterone derivative danazol. Blood count and coagulation status were checked before and during treatment. There was a significant increase (p less than 0…

article 1988
[Drug therapy of endometriosis].
Der Gynakologe
book-chapter 1987
Metabolic Effects of Hormonal Treatment for Endometriosis: Danazol versus LHRH-Agonist (Buserelin) Therapy
·doi:10.1159/000414863
article 1987
Metabolische Effekte und allgemeine Nebenwirkungen bei Endometriose-behandlung mit einem LHRH-Agonisten
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2008-1035798

Between 1983 and 1986 40 patients were treated for external genital endometriosis with the LHRH agonist buserelin. Ovarian suppression was achieved for a period of six months with a dose of 900 to 1,800 mcg per day. In addition to gynecolog…

article 1986
Effect of LH-RH agonist therapy in the treatment of endometriosis (German experience).
Progress in clinical and biological research
article 1986
Management of endometriosis.
Progress in clinical and biological research
article 1985
Ultrastructural changes in endometriotic tissue during danazol treatment
·doi:10.1016/s0015-0282(16)48794-7
article 1984
Changes of Plasma Lipids and Lipoprotein Levels during Danazol Treatment for Endometriosis
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme ·doi:10.1055/s-2007-1014859

Previous data of lipid and lipoprotein level changes with the application of danazol, an isoxazol derivative of 17-alpha-ethinyl testosterone, have been conflicting. We measured cholesterol, triglycerides, low density lipoproteins and high …

article 1984
Endocrine Dependency of Endometriosis
·doi:10.1097/00006254-198411000-00018

Laparoscopy permits identification of endometriotic foci, but the evaluation is not closely correlated with the histological and ultrastructural findings, which include a wide spectrum of variations. Endometriotic implants have been studied…

article 1984
Endocrine dependency of endometriosis: an ultrastructural study
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/0028-2243(84)90143-6
article 1984
Ultrastructural comparison of endometriotic implants and eutopic endometrium
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(84)90546-5
article 1981
Changes of Prolactin Secretion Following Long-Term Danazol Application
Fertility and Sterility ·doi:10.1016/s0015-0282(16)45915-7
article 1981
Ultrastructural changes in endometriotic implants during the menstrual cycle.

This report, the first ultrastructural study of endometriotic implants, compares the ectopic endometrium in 14 patients with that found in the uterus. The ultrastructural features of most of the glands of the ectopic endometrium resemble th…

article 1981
Ultrastructural Changes in Endometriotic Tissue During Danazol Treatment
Fertility and Sterility ·doi:10.1016/s0015-0282(16)45612-8